Indication

Ventricular fibrillation

Ventricular fibrillation is a severe, life-threatening cardiac arrhythmia and medical emergency affecting the cardiovascular system. Read more about Ventricular fibrillation

39 drugs 38 manufacturers

Advertisement

Drugs that treat it

Common Ventricular fibrillation therapies.

Showing 10–18 of 39 drugs

AMIODARONE HCL

LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
APP PHARMACEUTI

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
MYLAN INSTITUTI

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
TARO PHARM USA

AMIODARONE HCL

ANTIARRHYTHMIC - CLASS III·LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
AUROBINDO PHARM

AMIODARONE HCL

LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
APP/FRESENIUS K

AMIODARONE HCL

LIFE-THREATENING VENTRICULAR TACHYCARDIA·+2
WEST-WARD,INC.
Filter & compare in the drug finder →Opens the drug finder with Ventricular fibrillation preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ventricular fibrillation.

Ventricular fibrillation is a severe, life-threatening cardiac arrhythmia and medical emergency affecting the cardiovascular system.

It is characterized by rapid, highly disorganized electrical impulses within the ventricles, causing the myocardium to quiver erratically rather than contract synchronously.

This lack of coordinated mechanical pumping results in an immediate cessation of effective cardiac output, precipitating hemodynamic collapse, loss of consciousness, and pulseless cardiac arrest.

Most commonly triggered by myocardial ischemia, structural heart disease, or underlying channelopathies, it leads to sudden cardiac death within minutes if not rapidly terminated.

Personalize your experience

Follow Ventricular fibrillation and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it